Envoy Medical is trading 5.2% down at $0.67 as the stock faces continued volatility without a clear company-specific catalyst.
- The decline aligns with broader selling pressure currently affecting the small-cap and healthcare sectors.
- Recent trading has been characterized by unexplained price swings, including a bounce and reversal in the previous session.
- No major earnings, FDA developments, or corporate deal news have been reported to explain the move.